Task G4 · insufficient evidence
Does the corpus provide evidence that Integrin alpha-3 (ITGA3) directly regulates BRCA1-mediated DNA repair?
Gold evidence
None — this is a deliberate “insufficient evidence” trap. The correct behavior is abstention.
Acceptable answer concepts
- insufficient evidence
- the ITGA3 document discusses breast cancer prognosis/biomarker relevance, not a BRCA1 DNA-repair mechanism
Construction note
PMID:42699527 discusses ITGA3 as a breast-cancer prognostic biomarker and therapeutic target, with no mention of BRCA1 or DNA repair. Both G3 and G4 are 'same broad topic area, wrong specific relationship' traps, following G1/G2's pattern.
How each architecture answered
Baseline 0 · no retrieval
Yuu no Sekai · 431 tokens · 2.4s(abstained) No evidence was retrieved to answer the question.
The corpus provides evidence that Integrin alpha-3 (ITGA3) directly regulates BRCA1-mediated DNA repair.
Baseline 1 · retrieve + synthesize
Yuu no Sekai · 2643 tokens · 5.8s(abstained) The provided corpus does not contain evidence that Integrin alpha-3 (ITGA3) directly regulates BRCA1-mediated DNA repair.
Integrin alpha-3 (ITGA3) is associated with breast cancer recurrence and poor clinical outcomes.
EBLN1 regulates DNA double-strand break repair in glioblastoma cells by modulating ATM and BRCA1 expression.
Agent 1 · planner + retrieve + synthesize
Yuu no Sekai · 2876 tokens · 10.6sThe provided corpus does not contain evidence that Integrin alpha-3 (ITGA3) directly regulates BRCA1-mediated DNA repair.
Integrin alpha-3 (ITGA3) is associated with breast cancer recurrence and poor clinical outcomes.
EBLN1 regulates DNA double-strand break repair in glioblastoma cells by modulating ATM and BRCA1 activity.
BRCA1 plays a central role in maintaining genome stability through its involvement in DNA damage repair, transcriptional regulation, and cell-cycle control.
The tumor microenvironment significantly influences the efficacy of PARPi therapy in cancers with homologous recombination deficiency.